Literature DB >> 24953457

Status and prognosis of lymph node metastasis in patients with cardia cancer - a systematic review.

Cecilie Okholm1, Lars Bo Svendsen2, Michael P Achiam2.   

Abstract

BACKGROUND: Adenocarcinoma of the gastroesophageal junction (GEJ) has a poor prognosis and survival rates significantly decreases if lymph node metastasis is present. An extensive lymphadenectomy may increase chances of cure, but may also lead to further postoperative morbidity and mortality. Therefore, the optimal treatment of cardia cancer remains controversial. A systematic review of English publications dealing with adenocarcinoma of the cardia was conducted to elucidate patterns of nodal spread and prognostic implications.
METHODS: A systematic literature search based on PRISMA guidelines identifying relevant studies describing lymph node metastasis and the associated prognosis. Lymph node stations were classified according to the Japanese Gastric Cancer Association guidelines.
RESULTS: The highest incidence of metastasis is seen in the nearest regional lymph nodes, station no. 1-3 and additionally in no. 7, 9 and 11. Correspondingly the best survival is seen when metastasis remain in the most locoregional nodes and survival equally tends to decrease as the metastasis become more distant. Furthermore, the presence of lymph node metastasis significantly correlates to the TNM-stage. Incidences of metastasis in mediastinal lymph nodes are associated with poor survival.
CONCLUSION: The best survival rates is seen when lymph node metastasis remains locoregional and survival rates decreases when distant lymph node metastasis is present. The dissection of locoregional lymph nodes offers significantly therapeutic benefit, but larger and prospective studies are needed to evaluate the effect of dissecting distant and mediastinal lymph nodes.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Cardia cancer; Gastroesophageal junction; Lymph node metastasis; Lymphadenectomy; Prognosis

Mesh:

Year:  2014        PMID: 24953457     DOI: 10.1016/j.suronc.2014.06.001

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  13 in total

1.  Correlation Between the Increased Hospital Volume and Decreased Overall Perioperative Mortality in One Universal Health Care System.

Authors:  Jin-Ming Wu; Te-Wei Ho; Yu-Wen Tien
Journal:  World J Surg       Date:  2019-09       Impact factor: 3.352

Review 2.  Surgical approaches to adenocarcinoma of the gastroesophageal junction: the Siewert II conundrum.

Authors:  Andrew M Brown; Danica N Giugliano; Adam C Berger; Michael J Pucci; Francesco Palazzo
Journal:  Langenbecks Arch Surg       Date:  2017-08-12       Impact factor: 3.445

3.  Gastrointestinal Factor GDDR Attenuates Epithelial-Mesenchymal Transition in Gastric Cancer via Inhibiting AKT Signal.

Authors:  Cheng Fang; Ziqiang Zhang; Chaoxu Liu; Gang Wang; Fei Wang; Zhanwei Zhao; Wenhui Li; Jin Hua; Jianbo Shuang; Jianjun Du
Journal:  Dig Dis Sci       Date:  2016-03-26       Impact factor: 3.199

Review 4.  The extent of lymphadenectomy in esophageal resection for cancer should be standardized.

Authors:  Eliza R C Hagens; Mark I van Berge Henegouwen; Miguel A Cuesta; Suzanne S Gisbertz
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

5.  Gastric cardia adenocarcinoma microRNA profiling in Chinese patients.

Authors:  Shegan Gao; Fuyou Zhou; Chen Zhao; Zhikun Ma; Ruinuo Jia; Shuo Liang; Mengxi Zhang; Xiaojuan Zhu; Pengfei Zhang; Lu Wang; Feng Su; Jiangman Zhao; Gang Liu; Bo Peng; Xiaoshan Feng
Journal:  Tumour Biol       Date:  2016-01-18

6.  CXCL1 expression is correlated with Snail expression and affects the prognosis of patients with gastric cancer.

Authors:  Zhen Xiang; DA-Ping Jiang; Guang-Gai Xia; Zhe-Wei Wei; Wei Chen; Yulong He; Chang-Hua Zhang
Journal:  Oncol Lett       Date:  2015-08-14       Impact factor: 2.967

7.  The clinicopathologic characteristics and prognostic factors of gastroesophageal junction tumors according to Siewert classification.

Authors:  Bala Başak Öven Ustaalioğlu; Metin Tilki; Ali Sürmelioğlu; Ahmet Bilici; Can Gönen; Recep Ustaalioğlu; Özlem Balvan; Mehmet Aliustaoğlu
Journal:  Turk J Surg       Date:  2017-03-01

8.  Lymph node status after resection for gallbladder adenocarcinoma: prognostic implications of different nodal staging/scoring systems.

Authors:  Neda Amini; Gaya Spolverato; Yuhree Kim; Rohan Gupta; Georgios Antonios Margonis; Aslam Ejaz; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2014-10-13       Impact factor: 3.454

9.  Indication for endoscopic treatment based on the risk of lymph node metastasis in patients with Siewert type II/III early gastric cancer.

Authors:  Jeung Hui Pyo; Hyuk Lee; Yang Won Min; Byung-Hoon Min; Jun Haeng Lee; Kyoung-Mee Kim; Heejin Yoo; Soohyun Ahn; Jae J Kim
Journal:  Gastric Cancer       Date:  2017-12-14       Impact factor: 7.370

10.  N3 subclassification incorporated into the final pathologic staging of gastric cancer: a modified system based on current AJCC staging.

Authors:  Chun-Nan Yeh; Shang-Yu Wang; Jun-Te Hsu; Kun-Chun Chiang; Chi-Tung Cheng; Chun-Yi Tsai; Yu-Yin Liu; Chien-Hung Liao; Keng-Hao Liu; Ta-Sen Yeh
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.